The Cannabis ETF
Limited financial coverage for THCX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This Exchange Traded Fund (ETF) concentrates its investments within the cannabis sector. It aims to allocate a minimum of 80% of its total capital to the specific securities that make up its benchmark index. Furthermore, under typical market conditions, at least 80% of its net assets, including any funds borrowed for investment, will be directed into publicly traded common stocks or American Depositary Receipts (ADRs) of companies operating within the cannabis industry.
- IPO
- 2019
- HQ
- DE, US
Get TickerSpark's AI analysis on THCX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $12.90M
- Div Yield
- 2.92%
- 52W High
- $23.22
- 52W Low
- $14.90
- 50D MA
- $17.00
- 200D MA
- $17.41
- Beta
- 1.60
- RSI (14)
- 43
- Avg Volume
- 0
No earnings-call transcripts are available for THCX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 777.41K
- Float Shares
- 0
of shares held by institutions
1 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| American Portfolios Advisors | 4.39K | ▲ 1.50K |
| Fourthought Financial, LLC | 850 | 0 |
| Wipfli Financial Advisors LLC, | 510 | ▲ 510 |
| Next Financial Group, Inc | 302 | ▲ 163 |
| Carroll Financial Associates, Inc. | 115 | 0 |
| Crescent Capital Consulting, LLC | 21 | 0 |
Our THCX coverage
Recent articles, reports, and earnings notes.
No research on THCX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate THCX report →Christina Lake Cannabis Announces Non-Binding Letter of Intent
globenewswire.com · Aug 21
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD
247wallst.com · Aug 19
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
prnewswire.com · Aug 19
IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
prnewswire.com · Aug 18
Top Canadian Cannabis Stocks to Watch in August 2026
marijuanastocks.com · Aug 18
NewLake Capital: Discounted Cannabis REIT Offers Inflation-Beating Yields And Rich Upsides
seekingalpha.com · Aug 18
Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE
prnewswire.com · Aug 18
Tilray Medical Welcomes Progress in Germany's Medical Cannabis Framework and Supports Continued Policy Development
globenewswire.com · Aug 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.